Elevance Health, Inc. $ELV Shares Sold by Vancity Investment Management Ltd

Vancity Investment Management Ltd reduced its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 4.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 38,269 shares of the company’s stock after selling 1,851 shares during the period. Elevance Health makes up about 1.8% of Vancity Investment Management Ltd’s holdings, making the stock its 22nd largest position. Vancity Investment Management Ltd’s holdings in Elevance Health were worth $13,415,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Rossby Financial LCC lifted its stake in shares of Elevance Health by 110.0% in the third quarter. Rossby Financial LCC now owns 84 shares of the company’s stock valued at $28,000 after purchasing an additional 44 shares during the period. Kemnay Advisory Services Inc. purchased a new position in Elevance Health in the fourth quarter valued at about $31,000. J.Safra Asset Management Corp purchased a new position in Elevance Health in the fourth quarter valued at about $32,000. ORG Partners LLC lifted its position in shares of Elevance Health by 120.4% during the 4th quarter. ORG Partners LLC now owns 108 shares of the company’s stock valued at $38,000 after acquiring an additional 59 shares during the period. Finally, Dorato Capital Management purchased a new stake in shares of Elevance Health during the 4th quarter worth approximately $41,000. 89.24% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Jefferies Financial Group dropped their price objective on Elevance Health from $395.00 to $391.00 and set a “buy” rating for the company in a research note on Monday, April 20th. Guggenheim upped their target price on Elevance Health from $396.00 to $399.00 and gave the company a “buy” rating in a report on Friday, April 24th. The Goldman Sachs Group raised their price target on Elevance Health from $350.00 to $370.00 and gave the company a “neutral” rating in a research report on Friday, April 24th. Mizuho boosted their price objective on shares of Elevance Health from $435.00 to $465.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, Barclays increased their price objective on shares of Elevance Health from $408.00 to $480.00 and gave the company an “overweight” rating in a research note on Tuesday, May 26th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $416.11.

Elevance Health Stock Performance

NYSE ELV opened at $388.77 on Friday. Elevance Health, Inc. has a fifty-two week low of $273.71 and a fifty-two week high of $426.98. The stock has a market cap of $84.43 billion, a price-to-earnings ratio of 16.54, a price-to-earnings-growth ratio of 2.21 and a beta of 0.67. The business has a fifty day moving average of $373.89 and a 200-day moving average of $346.61. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.70.

Elevance Health (NYSE:ELV) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, beating analysts’ consensus estimates of $10.74 by $1.84. The business had revenue of $49.49 billion for the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The business’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter last year, the company earned $11.97 earnings per share. Elevance Health has set its FY 2026 guidance at 19.850- EPS. As a group, analysts predict that Elevance Health, Inc. will post 26.93 earnings per share for the current fiscal year.

Elevance Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Wednesday, June 10th will be paid a dividend of $1.72 per share. This represents a $6.88 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Wednesday, June 10th. Elevance Health’s dividend payout ratio (DPR) is currently 29.26%.

Insider Activity

In other news, Director Robert L. Dixon, Jr. sold 151 shares of Elevance Health stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $401.77, for a total transaction of $60,667.27. Following the completion of the sale, the director directly owned 10,734 shares in the company, valued at $4,312,599.18. The trade was a 1.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.34% of the stock is owned by corporate insiders.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.